BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38201282)

  • 81. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
    Karantanos T; Jones RJ
    Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
    Harada Y; Harada H
    J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
    Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
    PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia.
    Cui W; Kong NR; Ma Y; Amin HM; Lai R; Chai L
    Mod Pathol; 2006 Dec; 19(12):1585-92. PubMed ID: 16998462
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Myelodysplastic syndrome with translocation (8;21): a distinct myelodysplastic syndrome entity or M2-acute myeloid leukemia with extensive myeloid maturation?
    Kojima K; Omoto E; Hara M; Sasaki K; Katayama Y; Nawa Y; Kimura Y; Azuma T; Takimoto H; Harada M
    Ann Hematol; 1998 Jun; 76(6):279-82. PubMed ID: 9692817
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
    Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
    [TBL] [Abstract][Full Text] [Related]  

  • 88. N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation.
    Shen S; Passioura T; Symonds G; Dolnikov A
    Exp Hematol; 2007 Jun; 35(6):908-19. PubMed ID: 17533045
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
    Bonnet D; Dick JE
    Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes.
    Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia.
    Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H
    Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
    Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
    Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
    [TBL] [Abstract][Full Text] [Related]  

  • 95. MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.
    Buechele C; Breese EH; Schneidawind D; Lin CH; Jeong J; Duque-Afonso J; Wong SH; Smith KS; Negrin RS; Porteus M; Cleary ML
    Blood; 2015 Oct; 126(14):1683-94. PubMed ID: 26311362
    [TBL] [Abstract][Full Text] [Related]  

  • 96. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
    Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
    Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
    Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pretreatment CD34
    Jentzsch M; Geus U; Grimm J; Vucinic V; Pönisch W; Franke GN; Behre G; Niederwieser D; Schwind S
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1560-1566. PubMed ID: 30928626
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
    Alanazi B; Munje CR; Rastogi N; Williamson AJK; Taylor S; Hole PS; Hodges M; Doyle M; Baker S; Gilkes AF; Knapper S; Pierce A; Whetton AD; Darley RL; Tonks A
    Leukemia; 2020 Feb; 34(2):427-440. PubMed ID: 31611628
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Reconstruction of Human AML Using Functionally and Immunophenotypically Defined Human Haematopoietic Stem and Progenitor Cells as Targeted Populations.
    Zeisig BB; Fung TK; Troadec E; So CWE
    Bio Protoc; 2021 Dec; 11(24):e4262. PubMed ID: 35087921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.